Author

S. J. McIlwain

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 4 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1

Frequent Co-Authors

I. M. Ong· 4 shared M. C. Skala· 2 shared A. A. Gillette· 1 shared A. C. Palmenberg· 1 shared A. E. Xu· 1 shared A. Feils· 1 shared A. H. Yeung· 1 shared A. Hoefges· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

I. M. Ong

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Assessing Immune Factors in Maternal Milk and Paired Infant Plasma Antibody Binding to Human Rhinoviruses

J. M. Vera, S. J. McIlwain, S. Fye, A. Palmenberg, Y. A. Bochkov, H. Li, R. Pinapati, J. Tan, J. Gern, C. M. Seroogy, I. M. Ong

The paper identifies maternal milk and infant plasma antibody binding to human rhinovirus epitopes using high-density peptide arrays, revealing isotype-specific and virus-specific binding patterns.

bioRxiv · Dec 17, 2023Immunology

Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy

A. Hoefges, S. J. McIlwain, A. K. Erbe, N. N. Mathers, A. E. Xu, D. Melby, K. Tetreault, T. Q. Le, K. Kim, R. S. Pinapati, B. Garcia, J. Patel, M. Heck, A. Feils, N. Tsarovsky, , P. M. Sondel

The paper identifies antibodies targeting melanoma peptides in C57BL/6 mice cured of B78 melanoma via immunotherapy, using proteome arrays and ELISA validation.

bioRxiv · Feb 24, 2023 · PreprintImmunology

Inflammatory CD4/CD8 double positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology

N. J. Hess, D. P. Turicek, J. Riendeau, S. J. McIlwain, E. Contreras Guzman, K. Nadiminti, A. Hudson, N. S. Callander, M. C. Skala, J. E. Gumperz, P. Hematti, C. M. Capitini

This study identifies CD4+/CD8+ double positive T cells as mediators of xenogeneic GVHD but with limited GVL activity.

bioRxiv · Jan 11, 2022Immunology

Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity

J. D. Kratz, S. Rehman, K. A. Johnson, A. A. Gillette, A. Sunil, P. F. Favreau, C. A. Pasch, D. Miller, L. C. Zarling, A. H. Yeung, L. Clipson, S. J. Anderson, A. K. DeZeeuw, C. M. Sprackling, K. K. Lemmon, , D. A. Deming

The paper evaluates individual patient-derived cancer organoids using optical metabolic imaging to predict therapeutic response and identify subclonal populations and resistance mechanisms.

bioRxiv · Oct 15, 2021 · PreprintCancer Biology

The landscape of antibody binding in SARS-CoV-2 infection

A. S. Heffron, S. J. McIlwain, M. F. Amjadi, D. A. Baker, S. Khullar, A. K. Sethi, A. C. Palmenberg, M. A. Shelef, D. H. O'Connor, I. M. Ong

This study identifies B cell epitopes across the SARS-CoV-2 proteome using peptide microarrays, showing antibody reactivity to multiple viral proteins and correlations with illness severity.

bioRxiv · Oct 10, 2020 · PreprintImmunology